See Web addenda 5.4.
Recommendations on antithrombotic therapy in patients with peripheral arterial diseases
 |
|
AF = atrial fibrillation; CAS = carotid artery stenosis; CHA2DS2-VASc = Congestive heart failure, Hypertension, Age ≥75 (2 points), Diabetes mellitus, Stroke or TIA (2 points), Vascular disease, Age 65–74 years, Sex category; DAPT = dual antiplatelet therapy; LEAD = lower extremity artery disease; OAC = oral anticoagulation; PADs = peripheral arterial diseases; SAPT = single antiplatelet therapy.
CHA2DS2-VASc score is calculated as follows: congestive heart failure history (1 point), hypertension (1 point), age >75 years (2 points), diabetes mellitus (1 point), stroke or TIA or arterial thromboembolic history (1 point), vascular disease history (1 point), age 65–74 years (1 point), sex category (1 point if female).
Class of recommendation.
Level of evidence.
With the exception of patients with an indication for long-term OAC.
Without any other clinical cardiovascular condition requiring antiplatelet therapy (e.g. coronary artery disease or other multisite artery diseases).
Recommendations on antithrombotic therapy in patients with peripheral arterial diseases
|
|
AF = atrial fibrillation; CAS = carotid artery stenosis; CHA2DS2-VASc = Congestive heart failure, Hypertension, Age ≥75 (2 points), Diabetes mellitus, Stroke or TIA (2 points), Vascular disease, Age 65–74 years, Sex category; DAPT = dual antiplatelet therapy; LEAD = lower extremity artery disease; OAC = oral anticoagulation; PADs = peripheral arterial diseases; SAPT = single antiplatelet therapy.
CHA2DS2-VASc score is calculated as follows: congestive heart failure history (1 point), hypertension (1 point), age >75 years (2 points), diabetes mellitus (1 point), stroke or TIA or arterial thromboembolic history (1 point), vascular disease history (1 point), age 65–74 years (1 point), sex category (1 point if female).
Class of recommendation.
Level of evidence.
With the exception of patients with an indication for long-term OAC.
Without any other clinical cardiovascular condition requiring antiplatelet therapy (e.g. coronary artery disease or other multisite artery diseases).
